133 related articles for article (PubMed ID: 32995109)
1. Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential.
Pathak N; Cheruku SP; Rao V; Vibhavari RJA; Sumalatha S; Gourishetti K; Rao CM; Kumar N
3 Biotech; 2020 Oct; 10(10):438. PubMed ID: 32995109
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of sulfasalazine-induced cytotoxicity in C6 rat glioma cells.
Ignarro RS; Facchini G; de Melo DR; Pelizzaro-Rocha KJ; Ferreira CV; Castilho RF; Rogerio F
Neurosci Lett; 2017 Jan; 638():189-195. PubMed ID: 28007652
[TBL] [Abstract][Full Text] [Related]
4. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
5. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
Li M; Liang RF; Wang X; Mao Q; Liu YH
Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909
[TBL] [Abstract][Full Text] [Related]
6. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
7. Effect of dehydrozingerone, a half analog of curcumin on dexamethasone-delayed wound healing in albino rats.
Rao MC; Sudheendra AT; Nayak PG; Paul P; Kutty GN; Shenoy RR
Mol Cell Biochem; 2011 Sep; 355(1-2):249-56. PubMed ID: 21567208
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
9. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
[TBL] [Abstract][Full Text] [Related]
10. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model.
Zhang X; Guo M; Shen L; Hu S
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):603-12. PubMed ID: 25449156
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells.
Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC
Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
13. The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine.
Karbownik MS; Pietras T; Szemraj J; Kowalczyk E; Nowak JZ
Contemp Oncol (Pozn); 2014; 18(5):323-8. PubMed ID: 25477754
[TBL] [Abstract][Full Text] [Related]
14. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
[TBL] [Abstract][Full Text] [Related]
15. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
Wang H; Ren S; Xu Y; Miao W; Huang X; Qu Z; Li J; Liu X; Kong P
Anticancer Drugs; 2019 Jan; 30(1):81-88. PubMed ID: 30273182
[TBL] [Abstract][Full Text] [Related]
17. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
Wang N; Zhang Q; Ning B; Luo L; Fang Y
Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
[TBL] [Abstract][Full Text] [Related]
18. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like activity of dehydrozingerone: involvement of the serotonergic and noradrenergic systems.
Martinez DM; Barcellos A; Casaril AM; Savegnago L; Lernardão EJ
Pharmacol Biochem Behav; 2014 Dec; 127():111-7. PubMed ID: 25449795
[TBL] [Abstract][Full Text] [Related]
20. Dehydrozingerone promotes healing of diabetic foot ulcers: a molecular insight.
Begum F; Manandhar S; Kumar G; Keni R; Sankhe R; Gurram PC; Beegum F; Teja MS; Nandakumar K; Shenoy RR
J Cell Commun Signal; 2023 Sep; 17(3):673-688. PubMed ID: 36280629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
